A targeted combinatorial therapy for Ewing's sarcoma
- 1 October 2021
- journal article
- research article
- Published by Elsevier in Nanomedicine: Nanotechnology, Biology and Medicine
- Vol. 37, 102446
Abstract
No abstract availableKeywords
Funding Information
- Jazan University
- Oregon State University
- National Institutes of Health (R01CA237569, R37CA234006)
- Najran University
- National Cancer Institute
- Oregon Health and Science University
- National Center for Advancing Translational Sciences (KL2 TR002370)
This publication has 32 references indexed in Scilit:
- Polymeric Micelles as Carriers for Nerve-Highlighting Fluorescent Probe DeliveryMolecular Pharmaceutics, 2015
- Ewing Sarcoma: Current Management and Future Approaches Through CollaborationJournal of Clinical Oncology, 2015
- Naphthalocyanine-Based Biodegradable Polymeric Nanoparticles for Image-Guided Combinatorial PhototherapyChemistry of Materials, 2015
- Nanostructured lipid carriers as multifunctional nanomedicine platform for pulmonary co-delivery of anticancer drugs and siRNAJournal of Controlled Release, 2013
- Biomarkers in Ewing sarcoma: the promise and challenge of personalized medicine. A report from the Children’s Oncology GroupFrontiers in Oncology, 2013
- Towards Endometriosis Diagnosis by Gadofosveset-Trisodium Enhanced Magnetic Resonance ImagingPLOS ONE, 2012
- Quantitative Methods for Assessing Drug SynergismGenes & Cancer, 2011
- Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay MethodCancer Research, 2010
- Ewing's Sarcoma Family of Tumors: Current ManagementThe Oncologist, 2006
- Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitorsAdvances in Enzyme Regulation, 1984